Effects of steroids on plasma proteins--progestational agents.
D000293:Adolescent; D000328:Adult; D000510:Alpha-Globulins / Q000032:analysis; D000726:Androgen Antagonists; D000818:Animals; D001798:Blood Proteins / Q000032:analysis*; D002715:Chlormadinone Acetate / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003276:Contraceptives, Oral / Q000009:adverse effects; D004394:Dydrogesterone / Q000494:pharmacology*; D005003:Ethisterone / Q000494:pharmacology*; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005966:Glucuronidase / Q000097:blood; D000882:Haplorhini; D006242:Haptoglobins / Q000032:analysis; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D008525:Medroxyprogesterone / Q000494:pharmacology*; D009640:Norethindrone / Q000494:pharmacology*; D010958:Plasminogen / Q000032:analysis; D011278:Pregnanes / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology*; D013923:Thromboembolism / Q000139:chemically induced; D013975:Thyroxine-Binding Proteins / Q000032:analysis; D014156:Transcortin / Q000032:analysis; D014361:Trypsin Inhibitors / Q000097:blood
D000510:Alpha-Globulins; D000726:Androgen Antagonists; D001798:Blood Proteins; D003276:Contraceptives, Oral; D006242:Haptoglobins; D011278:Pregnanes; D013975:Thyroxine-Binding Proteins; D014361:Trypsin Inhibitors; D002715:Chlormadinone Acetate; D011374:Progesterone; D005340:Fibrinogen; D010958:Plasminogen; D014156:Transcortin; D004394:Dydrogesterone; D005966:Glucuronidase; D008525:Medroxyprogesterone; D005003:Ethisterone; D009640:Norethindrone; D006854:Hydrocortisone